BioMarker Strategies Announces Publication of Research to Identify Dynamic Biomarkers to Better Predict and Enhance Response to Cetuximab in Patients with Head and Neck/Esophageal Squamous Cell Carcinoma
ROCKVILLE, Md.–(BUSINESS WIRE)–BioMarker Strategies today announced that the journal CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS has published a manuscript by the Company’s scientists entitled “Functional Profiling of Head and Neck/Esophageal Squamous Cell Carcinoma to Predict Cetuximab Response”. The manuscript describes the company’s progress in identifying predictive dynamic biomarkers to help identify the subset of patients with head … [Read more…]
